EXHIBIT 10.2
ADDENDUM NO. 4
TO MASTER LEASE AGREEMENT
DATED AS OF SEPTEMBER 19, 1996
THIS ADDENDUM (this "Addendum") amends and supplements the above referenced
lease (the "Lease"), between General Electric Capital Corporation ("Lessor") and
Millennium Pharmaceuticals, Inc. ("Lessee") and is hereby incorporated into the
Lease as though fully set forth therein. Capitalized terms not otherwise defined
herein shall have the meanings set forth in the Lease.
Solely to the extent relating to Schedules executed an delivered from and after
the date hereof, the Lease is hereby amended by inserting the following Section
XXI therein.
"XXI. ADDITIONAL COVENANTS.
(a) At all times during the term of the Lease, Lessee shall
maintain, on a consolidated basis, unrestricted cash, cash equivalents and
marketable securities of at least $50,000,000. In the event Lessee at any
time fails to maintain unrestricted cash, cash equivalent and marketable
securities in the amounts required above, within fifteen (15) days after
Lessee ceases to satisfy such requirement, Lessee shall cause to be
delivered to Lessor an irrevocable standby letter of credit as described
in Section XXI(c) below. Unrestricted cash, cash equivalents and
marketable securities shall be defined as being net of any non-GE Capital
contingent liabilities associated with other lease or loan cash triggers,
pledge agreements, etc. Except as defined herein, accounting terms used
herein shall be as defined, and all calculations hereunder shall be made,
in accordance with GAAP.
(b) If Lessee's unrestricted cash, cash equivalents and marketable
securities shall ever total $400,000,000 or less, Lessee's chief financial
officer or Treasurer shall notify Lessor of the amount of Lessee's
consolidated unrestricted cash, cash equivalents and marketable securities
and shall certify that such amounts are in compliance with the
requirements of Section XXI(a) above, such notification and certification
shall be provided within fifteen (15) days after the end of each month,
reflecting such information as of the end of the month immediately
preceding such notice. If Lessee fails timely to provide such notification
and compliance certificates, within fifteen (15) days after such failure,
Lessee shall cause to be delivered to Lessor an irrevocable standby letter
of credit as described in Section XXI(c) below. A failure by Lessee to
provide such Letter of Credit or otherwise comply with this Section XXI
shall be a default hereunder.
(c) The irrevocable standby letter of credit provided pursuant to
this addendum shall be (i) in the amount of the then Stipulated Loss Value
of all of the Schedules, (ii) issued by a bank which is acceptable to
Lessor in its sole discretion, (iii) in the form attached as Exhibit A or
as may be acceptable to Lessor in its sole discretion, and (iv) for an
initial term of one (1) year with automatic annual renewals thereafter
(without amendment except for extension of the then current expiration
date by an additional year) until Lessee has received written notice from
Lessor to the effect that the Letter of credit is being released in its
entirety. Lessee shall also execute a Letter of Credit Agreement in the
form attached as Exhibit B."
The parties agree that the amendment set forth in paragraph 1 of Addendum No. 1
shall not be applicable to Schedules executed and delivered after the date
hereof. Except as expressly modified hereby, all terms and provisions of the
Lease shall remain in full force and effect. This Addendum is not binding nor
effective with respect to the Lease or the Equipment until executed on behalf of
Lessor and Lessee by authorized representatives of Lessor and Lessee.
IN WITNESS WHEREOF, Lessee and Lessor have caused this Addendum to be executed
by their duly authorized representatives as of this 28 day of February, 2001
LESSOR: LESSEE:
GENERAL ELECTRIC CAPITAL CORPORATION MILLENNIUM PHARMACEUTICALS, INC.
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇
Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ Name: ▇▇▇▇▇ ▇. ▇▇▇▇▇
Title: Senior Transaction Mgr. Title: Treasurer
Attest:
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇